We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Lockheed Martin (LMT) Wins $273.5M THAAD Interceptor Deal
Read MoreHide Full Article
Lockheed Martin Corp.’s (LMT - Free Report) Missiles and Fire Control (MFC) business unit recently secured a contract for supplying the 9th Lot of Terminal High Altitude Area Defense (THAAD) interceptors to the U.S. Missile Defense Agency. The company expects to complete work under this deal by Mar 31, 2020.
Details of the Deal
Valued at $273.5 million, the contract was awarded by the Missile Defense Agency, Huntsville, AL. Per the terms of the agreement, Lockheed Martin will produce the 9th Lot of interceptors and one-shot devices in addition to providing associated production support.
Work related to the contract will be carried out in Dallas, TX; Camden, AK; Huntsville, Anniston and Troy, AL. The company plans to utilize fiscal 2017 procurement funds to finance this deal.
A Brief Note on THAAD
THAAD is an anti-missile system which can intercept and eliminate short- and medium range ballistic missiles. It is the only transportable missile defense system with the operational flexibility to intercept in both within and outside the Earth’s atmosphere for providing versatile capability to fighters.
What’s Favoring Lockheed?
Lockheed Martin’s MFC business unit derives a major portion of its revenue from its air and missile defense product line, with THAAD being a notable contributor. In 2016, the MFC business segment generated sales of $6.6 billion, which represented 14% of Lockheed Martin’s total sales. U.S. government customers accounted for 61% of this sales figure, while international customers accounted for 37%, reflecting strong demand for such products across the globe.
In fact, the company claims to be the world leader in missile defense, with its systems having achieved more than 100 successful intercepts in combat and flight testing since 1984 – more than any other company – and 50 successful target missions since 1996.
Being the Pentagon’s prime defense contractor, Lockheed Martin enjoys a lion’s share of the aerospace-defense industry in the U.S. On top of that, $13.5 billion of the additional $25 billion budget proposal that came from President Trump for core Defense Department programs for the current fiscal year, has been allocated for a number of defense equipments including THAAD. This surely, if accepted, will boost Lockheed Martin’s revenue growth. Going forward, more of such contracts can be expected in the future, given that THAAD is one of the top priorities in the Pentagon’s missile system.
Price Performance
Lockheed Martin underperformed the Zacks categorized Aerospace/Defense industry in the last one year, with the company’s gain of 20.7% being lower than the industry’s addition of 24.3%. This might have been triggered by intense competition from some of the largest defense primes in the U.S., particularly The Boeing Company (BA - Free Report) , Northrop Grumman Corp. (NOC - Free Report) and Embraer S.A. (ERJ - Free Report) . Also, the current quarter EPS estimates for the company came down by 5 cents over the past 60 days, which reflects investors’ reluctance to consider the stock as a suitable investment option for the time being.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Lockheed Martin (LMT) Wins $273.5M THAAD Interceptor Deal
Lockheed Martin Corp.’s (LMT - Free Report) Missiles and Fire Control (MFC) business unit recently secured a contract for supplying the 9th Lot of Terminal High Altitude Area Defense (THAAD) interceptors to the U.S. Missile Defense Agency. The company expects to complete work under this deal by Mar 31, 2020.
Details of the Deal
Valued at $273.5 million, the contract was awarded by the Missile Defense Agency, Huntsville, AL. Per the terms of the agreement, Lockheed Martin will produce the 9th Lot of interceptors and one-shot devices in addition to providing associated production support.
Work related to the contract will be carried out in Dallas, TX; Camden, AK; Huntsville, Anniston and Troy, AL. The company plans to utilize fiscal 2017 procurement funds to finance this deal.
A Brief Note on THAAD
THAAD is an anti-missile system which can intercept and eliminate short- and medium range ballistic missiles. It is the only transportable missile defense system with the operational flexibility to intercept in both within and outside the Earth’s atmosphere for providing versatile capability to fighters.
What’s Favoring Lockheed?
Lockheed Martin’s MFC business unit derives a major portion of its revenue from its air and missile defense product line, with THAAD being a notable contributor. In 2016, the MFC business segment generated sales of $6.6 billion, which represented 14% of Lockheed Martin’s total sales. U.S. government customers accounted for 61% of this sales figure, while international customers accounted for 37%, reflecting strong demand for such products across the globe.
In fact, the company claims to be the world leader in missile defense, with its systems having achieved more than 100 successful intercepts in combat and flight testing since 1984 – more than any other company – and 50 successful target missions since 1996.
Being the Pentagon’s prime defense contractor, Lockheed Martin enjoys a lion’s share of the aerospace-defense industry in the U.S. On top of that, $13.5 billion of the additional $25 billion budget proposal that came from President Trump for core Defense Department programs for the current fiscal year, has been allocated for a number of defense equipments including THAAD. This surely, if accepted, will boost Lockheed Martin’s revenue growth. Going forward, more of such contracts can be expected in the future, given that THAAD is one of the top priorities in the Pentagon’s missile system.
Price Performance
Lockheed Martin underperformed the Zacks categorized Aerospace/Defense industry in the last one year, with the company’s gain of 20.7% being lower than the industry’s addition of 24.3%. This might have been triggered by intense competition from some of the largest defense primes in the U.S., particularly The Boeing Company (BA - Free Report) , Northrop Grumman Corp. (NOC - Free Report) and Embraer S.A. (ERJ - Free Report) . Also, the current quarter EPS estimates for the company came down by 5 cents over the past 60 days, which reflects investors’ reluctance to consider the stock as a suitable investment option for the time being.
Zacks Rank
Lockheed Martin currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>